Clinical Trials on Mucopolysaccharidosis Type VII in Korea, Republic of
Total 4149 results
-
CinnagenCompletedMucopolysaccharidosis Type 1Iran, Islamic Republic of
-
Green Cross CorporationCompleted
-
Green Cross CorporationUnknownThe Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) PatientsHunter SyndromeKorea, Republic of
-
GC Biopharma CorpRecruitingMucopolysaccharidosis II | Hunter SyndromeKorea, Republic of
-
Green Cross CorporationCompletedMucopolysaccharidosis IIKorea, Republic of
-
Green Cross CorporationCompleted
-
Ultragenyx Pharmaceutical IncCompletedMucopolysaccharidosis | Sly Syndrome | Mucopolysaccharidosis VII | MPS VIISpain, United States, Portugal
-
Ultragenyx Pharmaceutical IncPRA Health SciencesRecruitingSly Syndrome | Mucopolysaccharidosis VII | MPS VII | MPS 7United States, Germany, Brazil, Argentina, France, Netherlands, Portugal, Spain, Turkey
-
Tehran University of Medical SciencesUnknownMucopolysaccharidosisIran, Islamic Republic of
-
Seoul National University HospitalUnknownProstate Cancer Recurrent | Stage II Prostate Carcinoma | Stage III Prostate CarcinomaKorea, Republic of
-
Yonsei UniversityCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Boryung Pharmaceutical Co., LtdRecruitingStage II Colon Cancer | Stage III Colon CancerKorea, Republic of
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II Diabetes MellitusKorea, Republic of
-
BayerCompleted
-
Korean Breast Cancer Study GroupUnknownBreast Cancer Stage II | Breast Cancer Stage IIIKorea, Republic of
-
BioMarin PharmaceuticalCompletedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IV AUnited States, Canada, France, Taiwan, Argentina, Colombia, Spain, Turkey, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, United Kingdom, Germany, Norway, Portugal, Italy, Qatar
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaWithdrawnPercutaneous Intervention Via Femoral ArteryKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedDyslipidemia | Type II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Yonsei UniversityCompletedEpilepsy and Focal Cortical Dysplasia IIKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyMerck Ltd.CompletedHypertension | Diabetes Mellitus, Type IIKorea, Republic of
-
Yuhan CorporationCompletedType 2 Diabetes Mellitus | HypercholesterolemiaKorea, Republic of
-
SanofiRecruitingOsteochondrodysplasiaAustralia, Spain, Korea, Republic of, China, Italy
-
Yonsei UniversityUnknownNon-DM Stage II High-risk Colorectal Cancer | Non-DM Stage III Colorectal CancerKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
AJU Pharm Co., Ltd.CompletedType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes type2Korea, Republic of
-
Yonsei UniversityCompletedType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 DiabetesKorea, Republic of
-
Dong-A ST Co., Ltd.Completed
-
Chong Kun Dang PharmaceuticalCompletedEfficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType2 DiabetesKorea, Republic of
-
Yonsei UniversityUnknownType2 Diabetes With Depressive MoodKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingEfficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Dong-A ST Co., Ltd.CompletedType2 DiabetesKorea, Republic of